RGCC and myeloid sarcoma: RGC-32 has been shown to be present in MS brain tissue/MS plaques; statistically significantly lower levels of RGC-32 mRNA expression have been documented in the peripheral blood monocytes (PBMCs) of MS patients with relapses as compared to those who are clinically stable [17].